Ovarian reserve as measure of adjuvant chemotherapy benefit in HR-positive, HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER)
In premenopausal pts <55yrs, AMH was significantly better indicator of chemo benefit than menopause status, age
